Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01707836 · ClinicalTrials.gov registry record
Neurofibromatosis Type 1 Brain Tumor Genetic Risk
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 176
- Enrollment target
NCT01707836 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 176 participants.
The verdict
NCT01707836 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 176 participants
- Enrollment target
Study Summary
This study will analyze DNA samples to determine associations between maternal and offspring genetic factors and pediatric brain tumor development in children with Neurofibromatosis Type 1. Participating families (mother, father, child) will be asked to complete a short questionnaire and provide DNA samples (either saliva or blood). The information gained from your participation may one day help doctors develop strategies to reduce brain tumor risk in individuals with NF1. Please note: there is no therapy associated with this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 176 participants |
| Start Date | 2012-10 |
| Est. Completion | 2017-05-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01707836
The ClinicalTrials.gov registry entry for NCT01707836 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01707836 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01707836 about?
NCT01707836 is a clinical study titled "Neurofibromatosis Type 1 Brain Tumor Genetic Risk". This study will analyze DNA samples to determine associations between maternal and offspring genetic factors and pediatric brain tumor development in children with Neurofibromatosis Type 1. Participating families (mother, father, child) will be asked to complete a short questionnaire and provide DNA...
What is the current status of trial NCT01707836?
This trial is currently completed. The enrollment target is 176 participants. The study started on 2012-10. Estimated completion is 2017-05-08.
Who is sponsoring clinical trial NCT01707836?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.